Shareholder Interest

13 Oct 2005 17:20

Biotrace International PLC13 October 2005 For immediate release 13 October 2005 Biotrace International Plc (the "Company") Shareholder Interest Biotrace International a leading manufacturer of industrial microbiology andlife science products and services announces that yesterday it was informed thatArmor Capital Management, LLC and certain subsidiary companies have increasedtheir holding in Biotrace with the purchase of 350,000 ordinary shares. ArmorCapital Management, LLC now have an aggregated interest in 2,096,500 sharesrepresenting 5.34 per cent. of the issued share capital of the Company. The shares are held by the following entities:Armor Capital Partners, LP - 1,882,500 shares held at UBS Securities, LLC in New YorkAbeille Value Holdings, LLC - 24,000 shares held at UBS Securities, LLC in New YorkFirst New York Securities, LLC - 190,000 shares held at Bear Stearns Securities in New York For further information please contact Peter Morgan, Finance Director Tel: 01656 641400 This information is provided by RNS The company news service from the London Stock Exchange